Genetic studies have identified similarities between MS and MI involving common inflammatory pathways such as IL-17 [75], and the identification of the MHC2TA gene as a common point between the two pathologies strengthens the hypothesis of a predisposing genetic substrate [58], not yet fully elucidated. The gene discussed is IL17A; the disease is myeloid sarcoma.